Health Insurance (Accredited Pathology Laboratories—Approval) Amendment (Relevant Standards) Principles (No.1) 2023 (Cth)

Health Insurance (Accredited Pathology Laboratories—Approval) Amendment (Relevant Standards) Principles (No. 1) 2023

I, Mary Warner, as delegate of the Minister for Health and Aged Care, make the following principles.

Dated   22 February 2023

Mary Warner

Assistant Secretary
Medicare Benefits and Digital Health Division
Health Resourcing Group
Department of Health and Aged Care

Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments   2

Health Insurance (Accredited Pathology Laboratories—Approval) Principles 2017             2

1  Name

This instrument is the Health Insurance (Accredited Pathology Laboratories—Approval) Amendment (Relevant Standards) Principles (No.1) 2023.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.     The whole of this instrument	1 March 2023	1 March 2023

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 23DNA(1) of the Health Insurance Act 1973.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendment

Health Insurance (Accredited Pathology Laboratories – Approval) Principles 2017

1 Schedule 1 (table Item 3)

Repeal the item and substitute:
3	Requirements for Medical Testing for Human Genetic Variation (Third Edition 2022)	2022

2 Schedule 1 (table Item 4)

Repeal the item and substitute:
4	Requirements for Information Communication and Reporting (Fifth Edition 2022)	2022

3 Schedule 1 (table Item 6)

Repeal the item.

4 Schedule 1 (table Item 9)

Repeal the item and substitute:
9	Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials (Fifth Edition 2022)	2022

5 Schedule 1 (table Item 16)

Repeal the item and substitute:
16	Requirements for Transfusion Laboratory Practice (Fifth Edition 2022)	2022

6 Schedule 1 (table Item 20)

Repeal the item and substitute:
20	Requirements for the Development and Use of In-House In Vitro Diagnostic Medical Devices (Fourth Edition 2018)	2018

7 Schedule 1 (note at the end of the table)

Repeal the note, substitute:

The documents mentioned could in 2023 be viewed on the Australian Commission on Safety and Quality in Health Care’s pathology accreditation standards webpage.